Scn8a Developmental Epileptic Encephalopathy

• CLINICAL_TRIALS trial_result · 2025-07-17
  Clinical Trial Update: Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE [Phase 2]

  This is a Phase 2 extension study to assess the safety and tolerability of NBI-921352 as an adjunctive therapy for patients with SCN8A devel…